Southern Pathology Services, INC.
Southern Pathology Services, INC. was paid $5.72M by Medicaid between Jan 2018 and Dec 2024, across 31 billing codes. Its largest line is 87624, Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types — 27% of everything it billed.
PONCE, PR 00716
Next to other Clinical Medical Laboratory providers in Puerto Rico
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 13,732 | $442K | |
| 2019 | 13,993 | $460K | |
| 2020 | 15,769 | $550K | |
| 2021 | 29,115 | $1.05M | |
| 2022 | 27,867 | $976K | |
| 2023 | 28,572 | $933K | |
| 2024incomplete | 35,349 | $1.31M |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 27% | 40,609 | 37,078 | $1.57M |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 21% | 35,772 | 32,698 | $1.23M |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 21% | 36,075 | 32,958 | $1.20M |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 16% | 27,613 | 25,214 | $944K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 3.2% | 3,580 | 3,277 | $183K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 3.2% | 3,644 | 3,476 | $182K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 1.8% | 2,878 | 2,171 | $103K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 1.3% | 2,967 | 2,619 | $75K |
| 87481 | 1.1% | 2,016 | 1,730 | $65K | |
| 87563 | <1% | 1,960 | 1,698 | $50K | |
| 87511 | <1% | 1,082 | 999 | $35K | |
| 87070 | <1% | 3,348 | 3,070 | $27K |
19 more codes
| 87625 | <1% | 681 | $22K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 369 | $16K |
| 87536 | <1% | 59 | $5K | |
| 87071 | <1% | 418 | $4K | |
| 88142 | <1% | 108 | $3K | |
| 87081 | <1% | 413 | $3K | |
| 87186 | <1% | 348 | $3K | |
| 86360 | <1% | 44 | $2K | |
| 86769 | <1% | 41 | $1K | |
| 86703 | <1% | 49 | $571.25 | |
| 86328 | <1% | 22 | $519.28 | |
| 86592 | <1% | 123 | $486.14 | |
| 87653 | <1% | 15 | $473.34 | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 59 | $446.64 |
| 36415 | Collection of venous blood by venipuncture | <1% | 49 | $432.10 |
| 86361 | <1% | 15 | $400.36 | |
| 86780 | <1% | 14 | $171.26 | |
| 86593 | <1% | 14 | $61.06 | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
| Provider | Location | Paid |
|---|---|---|
| Southern Pathology Services, INC. | Ponce, PR | $18.95M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.